Older Adults with Type 1 Diabetes Set Ambitious Glycemic Targets

Many individuals aged 65 and above living with type 1 diabetes are striving for blood sugar targets that are typically set for much younger patients. Alarmingly, some even aim for levels lower than those recommended by their healthcare providers. This finding comes from a survey featured in the journal Discover Endocrinology and Metabolism, which explored the glycemic goals of seniors with type 1 diabetes and how they compare with the suggestions from their doctors.

Study Overview

The research involved 346 older adults from the T1D Exchange registry, collected between August and October of 2024. Conducted by a team including Anastasia-Stefania Alexopoulos and Anna R. Kahkoska, participants filled out electronic surveys detailing their diabetes management, including their personal target blood glucose ranges and the goals recommended by their healthcare providers. However, due to the study's recruitment method, the exact response rate couldn't be calculated.

Participants’ Profiles

The average age of participants was around 70 years, with a majority being female (63%) and predominantly White (96.5%). Most respondents were experienced in managing their diabetes: a whopping 96.9% used continuous glucose monitors, while 77.6% utilized insulin pumps. The personal blood glucose target ranges reported averaged 79 mg/dL at the low end and 169 mg/dL at the high end. The average hemoglobin A1c goal was 6.5%.

Discrepancy Between Goals

Notably, when asked about their providers’ recommendations, respondents indicated slightly more lenient goals: 79 mg/dL as a low end, 178 mg/dL as a high end, and a hemoglobin A1c target of 6.8%. To gauge the levels of agreement between patient-perceived goals and actual provider recommendations, researchers employed concordance correlation coefficients. They found only moderate alignment. For instance, correlations for the low and high ends of blood glucose targets were 0.63 and 0.52, respectively. Interestingly, the coefficient rose to 0.74 when comparing individual hemoglobin A1c targets with reported A1c levels, indicating many patients are successful in meeting their self-imposed standards.

The Challenges of Low Targets

The study's principal conclusion is that numerous participants set hemoglobin A1c goals below 7%, which aligns more closely with younger adults rather than older ones. This discrepancy highlights the challenges in adjusting glycemic targets in clinical practice. The data showed that discordance was particularly pronounced regarding the upper limits of glucose ranges, suggesting that older adults may be more averse to elevated blood sugar levels than their providers realize. Such feelings complicate shared decision-making processes in healthcare settings.

Understanding the Context

It is crucial to understand why this is significant. Older adults with diabetes are at higher risk for hypoglycemia, a potentially dangerous condition characterized by exceedingly low blood sugar. Clinical guidelines recommend that glycemic targets be tailored for this age group to prevent harm. Specifically, those without significant comorbidities may aim for hemoglobin A1c targets of 7 to 7.5%. Unfortunately, illness burden or cognitive decline necessitate looser targets to balance the risk of hypoglycemia against the marginal benefits of lower goals.

Implications for Treatment

Most respondents in this study reported a low burden of additional health conditions and utilized continuous glucose monitoring, which enhances safety regarding hypoglycemia. Thus, targeting a hemoglobin A1c below 7% could be reasonable for many participants. However, there might be opportunities missed in optimizing treatment approaches, especially among the approximately 25% of participants with hypoglycemia unawareness and the 20% who have cardiovascular issues.

Provider-Recommended Goals and Patient Preferences

Interestingly, even the goals reported by healthcare providers were stricter than recommended guidelines, averaging 6.8% as opposed to the less than 7% to 7.5% suggested for older adults. This scenario may indicate reluctance on the part of both patients and providers to relax glycemic targets, particularly among those who have effectively managed type 1 diabetes for years. The authors suggest that patient preferences should play a significant role in individualized treatment goals, but there is a need for education on current recommendations to facilitate informed shared decision-making.

Limitations and Future Research

The authors acknowledge limits within their study, such as its demographic homogeneity, as most participants were well-resourced, utilizing advanced monitoring technology. Moreover, since provider goals were self-reported by patients, these findings may not accurately reflect actual recommendations given by clinicians. Still, the study sheds light on how older adults manage their diabetes and perceive the alignment of their goals with those of their healthcare providers. It emphasizes the necessity for further research into why older adults may set stricter glycemic targets and how those discrepancies influence health outcomes.